Baird Initiates Coverage On Netstreit with Outperform Rating, Announces Price Target of $23
Baird analyst Wesley Golladay initiates coverage on Netstreit (NYSE:NTST) with a Outperform rating and announces Price Target of $23.
Raymond James Initiates Coverage On Globe Life with Strong Buy Rating, Announces Price Target of $138
Raymond James analyst Wilma Burdis initiates coverage on Globe Life (NYSE:GL) with a Strong Buy rating and announces Price Target of $138.
Raymond James Initiates Coverage On Unum with Market Perform Rating
Raymond James analyst Wilma Burdis initiates coverage on Unum (NYSE:UNM) with a Market Perform rating.
Raymond James Initiates Coverage On Voya Financial with Strong Buy Rating, Announces Price Target of $84
Raymond James analyst Wilma Burdis initiates coverage on Voya Financial (NYSE:VOYA) with a Strong Buy rating and announces Price Target of $84.
Raymond James Initiates Coverage On Prudential Financial with Strong Buy Rating, Announces Price Target of $115
Raymond James analyst Wilma Burdis initiates coverage on Prudential Financial (NYSE:PRU) with a Strong Buy rating and announces Price Target of $115.
Stephens & Co. Initiates Coverage On Westrock Coffee with Overweight Rating, Announces Price Target of $13
Stephens & Co. analyst Ben Bienvenu initiates coverage on Westrock Coffee (NASDAQ:WEST) with a Overweight rating and announces Price Target of $13.
Wedbush Initiates Coverage On Marqeta with Neutral Rating, Announces Price Target of $8
Wedbush analyst Moshe Katri initiates coverage on Marqeta (NASDAQ:MQ) with a Neutral rating and announces Price Target of $8.
RBC Capital Initiates Coverage On Fusion Fuel Green with Sector Perform Rating, Announces Price Target of $7
RBC Capital analyst Erwan Kerouredan initiates coverage on Fusion Fuel Green (NASDAQ:HTOO) with a Sector Perform rating and announces Price Target of $7.
RBC Capital Initiates Coverage On Nike with Outperform Rating, Announces Price Target of $125
RBC Capital analyst Piral Dadhania initiates coverage on Nike (NYSE:NKE) with a Outperform rating and announces Price Target of $125.
Capital One Initiates Coverage On RAPT Therapeutics with Overweight Rating, Announces Price Target of $48
Capital One analyst Zegbeh Jallah initiates coverage on RAPT Therapeutics (NASDAQ:RAPT) with a Overweight rating and announces Price Target of $48.